Majluf GE

Language: Spanish
References: 12
Page: 653-657
PDF size: 327.95 Kb.

ABSTRACT

Hereditary Angioedema (HAE) is an uncommon disease with possible fatal or serious outcomes during acute episodes and often there is a lack of knowledge for adequate diagnosis and therapy by health care providers. A vast number of sources of information were reviewed including the World Allergy Organization (WAO), 2012 guidelines for management of HAE. The aim of this article is to provide detailed and accessible information about HAE to Costa Rican health care providers and create a paradigm for guidelines to further appropriate diagnosis and management of patients with HAE in the country.

REFERENCES

1. Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 2006; 101:619.

2. Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003; 163:1229.

3. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001; 161:714.

4. Bowen T, Brosz J, Brosz K, et al. Management of hereditary angioedema: 2010 Canadian approach. Allergy Asthma Clin Immunol 2010; 6:20.

5. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus Figura 1. Algoritmo diagnóstico para HAE 1 y 2. Tomado de WAO Guideline for the management of Hereditary Angioedema, Craig et al. December 2012, World Allergy Organization Journal. algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010; 6:24.

6. Cicardi M, Bork K, Caballero T, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 2012; 67:147.

7. Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009; 124:801.

8. Craig, Timothy, Emel Aygören Pürsün, Konrad Bork, Tom Bowen, Henrik Boysen, Henriette Farkas, Anete Grumach, Constance H. Katelaris, Richard Lockey, Hilary Longhurst, William Lumry, Markus Magerl, Immaculada Martinez- Saguer, Bruce Ritchie, Alexander Nast, Ruby Pawankar, Bruce Zuraw, and Marcus Maurer. “WAO Guideline for the Management of Hereditary Angioedema.” World Allergy Organization Journal 5.12 (2012): 182-99. Web.

9. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139:379.

10. Kusuma A, Relan A, Knulst AC, et al. Clinical impact of peripheral attacks in hereditary angioedema patients. Am J Med 2012; 125:937. e17.

11. Longhurst HJ, Farkas H, Craig T, et al. HAE international home therapy consensus document. Allergy Asthma Clin Immunol 2010; 6:22.

12. Longhurst HJ, Carr S, Khair K. C1- inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option. Clin Exp Immunol 2007; 147:11.